BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma

Clinical trial NCT07002216 · RECRUITING

Trial details

NCT number: NCT07002216
Sponsor: University of Miami
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hodgkin Lymphoma Advanced Hodgkin Lymphoma

Start date: 2025-07-15
Primary completion: 2030-07-15
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.